Zentalis
PublicLast Round
Follow-on Offering
Jun 15, 2023
Total Funding Raised
$1.19B
Company Overview
Zentalis Pharmaceuticals (NAS: ZNTL) is a biopharmaceutical company focused on discovering and developing small molecule therapeutics that target key biological pathways in cancer.
Sector
Healthcare
AI Layer
Non-AI
Keywords
azenosertib (WEE1 inhibitor)small molecule cancer therapeuticsWEE1 inhibitor for solid tumorsplatinum-resistant ovarian cancer therapybiomarker-driven oncology drug developmenttargeted oncology drug pipelinecell cycle kinase inhibitororal SERD for breast cancerBCL-2 inhibitor for hematologic malignanciesEGFR inhibitor for non-small cell lung cancerpharmaceutical licensing and collaboration modelclinical-stage oncology company
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zentalis Comps
Public and private peers based on sector, stage, and business model.
Zentalis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Jun 15, 2023 | ||||
| Follow-on Offering | May 18, 2022 | ||||
| Private Placement | Apr 27, 2022 | ||||
| Follow-on Offering | Jul 1, 2021 | ||||
| Follow-on Offering | May 21, 2020 | ||||
IPO Announced | Apr 2, 2020 |
Zentalis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Matrix | Series C |
| Redmile Group | Series C |
| Jefferies | Follow-on Offering, IPO |
| Surveyor Capital | Series C |
| Farallon Capital Management | Series C |
| Perceptive Advisors | Series A, Series B, Series C |
| Guggenheim Securities | Follow-on Offering, IPO |
Zentalis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersNew York City, New York
Employee Range123
Year Founded2014
Last FundingJun 15, 2023
